Resection of a Transplantable Single-Nodule Hepatocellular Carcinoma in Child-Pugh Class A Cirrhosis: Factors Affecting Survival and Recurrence

被引：0
|
作者：
Fabrice Muscari
Bertrand Foppa
Nicolas Carrere
Nassim Kamar
Jean-Marie Peron
Bertrand Suc
机构：
[1] University Hospital of Rangueil,Liver Transplantation and Digestive Surgery Unit
[2] Epidemiology and Inserm U1027 Laboratory,Digestive Surgery Unit
[3] University Hospital of Purpan,Organ Transplantation and Nephrology Unit
[4] University Hospital of Rangueil,Hepatology Unit
[5] University Hospital of Purpan,undefined
[6] Service de Chirurgie Digestive et Transplantation Hépatique,undefined
[7] CHU Rangueil,undefined
来源：
World Journal of Surgery | 2011年 / 35卷
关键词：
Overall Survival; Portal Hypertension; Late Recurrence; Milan Criterion; Microvascular Invasion;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1055 / 1062
页数：7
相关论文
共 50 条
  • [21] Outcomes After Stereotactic Body Radiation for Hepatocellular Carcinoma in Patients With Child-Pugh A Versus Child-Pugh B/C Cirrhosis
    Diamond, Brett H.
    Banson, Kara
    Ayash, Jonathan
    Lee, Peter
    Shukla, Utkarsh C.
    Jones, Gavin
    Rava, Paul
    Fitzgerald, Thomas J.
    Sioshansi, Shirin
    ADVANCES IN RADIATION ONCOLOGY, 2024, 9 (12)
  • [22] Resection or ablation versus transarterial therapy for Child-Pugh A patients with a single small hepatocellular carcinoma
    Suh, Young Ju
    Jin, Young-Joo
    Jeong, Yujin
    Shin, Woo Young
    Lee, Jeong-Min
    Cho, Soongu
    Yu, Jung Hwan
    Lee, Jin-Woo
    MEDICINE, 2021, 100 (43) : E27470
  • [23] Sorafenib for hepatocellular carcinoma according to Child-Pugh class of liver function
    Fabio Farinati
    Anna Giacomin
    Veronica Vanin
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 1639 - 1640
  • [24] Sorafenib for hepatocellular carcinoma according to Child-Pugh class of liver function
    Kim, Jeong Eun
    Ryoo, Baek-Yeol
    Ryu, Min-Hee
    Chang, Heung-Moon
    Suh, Dong Jin
    Lee, Han Chu
    Lim, Young-Suk
    Kim, Kang Mo
    Kang, Yoon-Koo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (05) : 1285 - 1290
  • [25] Sorafenib for hepatocellular carcinoma according to Child-Pugh class of liver function
    Jeong Eun Kim
    Baek-Yeol Ryoo
    Min-Hee Ryu
    Heung-Moon Chang
    Dong Jin Suh
    Han Chu Lee
    Young-Suk Lim
    Kang Mo Kim
    Yoon-Koo Kang
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 1285 - 1290
  • [26] Sorafenib for hepatocellular carcinoma according to Child-Pugh class of liver function
    Jeong Eun Kim
    Baek-Yeol Ryoo
    Yoon-Koo Kang
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 1641 - 1642
  • [27] Sorafenib for hepatocellular carcinoma according to Child-Pugh class of liver function
    Farinati, Fabio
    Giacomin, Anna
    Vanin, Veronica
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (06) : 1639 - 1640
  • [28] Nomogram for predicting post-therapy recurrence in BCLC A/B hepatocellular carcinoma with Child-Pugh B cirrhosis
    Qiao, Wenying
    Sheng, Shugui
    Xiong, Yiqi
    Han, Ming
    Jin, Ronghua
    Hu, Caixia
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [29] Radiofrequency ablation versus resection for hepatocellular carcinoma in patients with Child-Pugh A liver cirrhosis: a meta-analysis
    Jia, J. B.
    Zhang, D.
    Ludwig, J. M.
    Kim, H. S.
    CLINICAL RADIOLOGY, 2017, 72 (12) : 1066 - 1075
  • [30] Hepatic resection for hepatocellular carcinoma in patients with Child-Pugh's A cirrhosis: is clinical evidence of portal hypertension a contraindication?
    Santambrogio, Roberto
    Kluger, Michael D.
    Costa, Mara
    Belli, Andrea
    Barabino, Matteo
    Laurent, Alexis
    Opocher, Enrico
    Azoulay, Daniel
    Cherqui, Daniel
    HPB, 2013, 15 (01) : 78 - 84
12345